The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Precision BioSciences, Inc(NASDAQ:DTIL)


Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company operates through two segments, Therapeutic and Food. It offers ARCUS, a genome editing platform to cure genetic disorders. The Therapeutic segment develops allogeneic CAR T immunoth...
Website: http://precisionbiosciences.com/
Founded: 2006
CEO: Matthew Kane
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Share this website to your friends
Precision BioSciences Days Payable Outstanding ttm (DPO)
Precision BioSciences Days Receivable Outstanding ttm (DSO)
Precision BioSciences Op Cashflow Per Share ttm
Precision BioSciences Free Cashflow Per Share ttm
Precision BioSciences Cash Per Share ttm
Precision BioSciences P/S ratio ttm
Precision BioSciences (GAAP) P/E ratio ttm
Precision BioSciences P/B ratio ttm
No extra charts and metrics for this ticker.